Finnish Firm Gets U.S. Patent for Covid Drug Containing Ivermectin and Hydroxychloroquine
May 25th, 2021Via: yle:
A coronavirus drug developed by Therapeutica Borealis, a pharmaceutical firm in Turku, has been granted a patent by the United States Patent and Trademark Office (USPTO). The nasal spray contains hydroxychloroquine, among other ingredients.
Earlier in May, the company said it had received approval for a patent application, based on which it expected a final patent this month.
…
According to the company, the nasal spray acts on cell function in nasal mucous in three ways, impairing the ability of the virus to penetrate the body and multiply, thus reducing the risk of serious illness.
Posted in Health | Top Of Page
